Progress towards therapies for disease modification in Parkinson's disease
N Vijiaratnam, T Simuni, O Bandmann… - The Lancet …, 2021 - thelancet.com
The development of interventions to slow or halt the progression of Parkinson's disease
remains a priority for patients and researchers alike. To date, no agents have been shown to …
remains a priority for patients and researchers alike. To date, no agents have been shown to …
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
K Khalaf, P Tornese, A Cocco, A Albanese - Translational …, 2022 - Springer
Most neurodegenerative disorders are diseases of protein homeostasis, with misfolded
aggregates accumulating. The neurodegenerative process is mediated by numerous …
aggregates accumulating. The neurodegenerative process is mediated by numerous …
Bile acid signaling pathways from the enterohepatic circulation to the central nervous system
KL Mertens, A Kalsbeek, MR Soeters… - Frontiers in …, 2017 - frontiersin.org
Bile acids are best known as detergents involved in the digestion of lipids. In addition, new
data in the last decade have shown that bile acids also function as gut hormones capable of …
data in the last decade have shown that bile acids also function as gut hormones capable of …
Tauroursodeoxycholate—bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives
M Kusaczuk - Cells, 2019 - mdpi.com
Tauroursodeoxycholic acid (TUDCA) is a naturally occurring hydrophilic bile acid that has
been used for centuries in Chinese medicine. Chemically, TUDCA is a taurine conjugate of …
been used for centuries in Chinese medicine. Chemically, TUDCA is a taurine conjugate of …
Application of metabolomics in Alzheimer's disease
JM Wilkins, E Trushina - Frontiers in neurology, 2018 - frontiersin.org
Progress toward the development of efficacious therapies for Alzheimer's disease (AD) is
halted by a lack of understanding early underlying pathological mechanisms. Systems …
halted by a lack of understanding early underlying pathological mechanisms. Systems …
Mitochondrial membrane permeabilization in cell death
Irrespective of the morphological features of end-stage cell death (that may be apoptotic,
necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is …
necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is …
The unfolded protein response: integrating stress signals through the stress sensor IRE1α
Stress induced by accumulation of unfolded proteins at the endoplasmic reticulum (ER) is a
classic feature of secretory cells and is observed in many tissues in human diseases …
classic feature of secretory cells and is observed in many tissues in human diseases …
[HTML][HTML] Neuroprotective strategies for retinal disease
Diseases that affect the eye, including photoreceptor degeneration, diabetic retinopathy, and
glaucoma, affect 11.8 million people in the US, resulting in vision loss and blindness. Loss of …
glaucoma, affect 11.8 million people in the US, resulting in vision loss and blindness. Loss of …
Bile acids: a communication channel in the gut-brain axis
VF Monteiro-Cardoso, M Corlianò… - NeuroMolecular …, 2021 - Springer
Bile acids are signalling hormones involved in the regulation of several metabolic pathways.
The ability of bile acids to bind and signal through their receptors is modulated by the gut …
The ability of bile acids to bind and signal through their receptors is modulated by the gut …
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow, J van Raamsdonk, D Rogers… - Human molecular …, 2003 - academic.oup.com
An expanded CAG repeat is the underlying genetic defect in Huntington disease, a disorder
characterized by motor, psychiatric and cognitive deficits and striatal atrophy associated with …
characterized by motor, psychiatric and cognitive deficits and striatal atrophy associated with …